Article Information
History
- July 11, 2018.
Article Versions
- Version 1 (February 18, 2018 - 16:33).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Romain F. Laine1,*,†,
- Gemma Goodfellow1,
- Laurence J. Young1,
- Jon Travers2,
- Danielle Carroll3,
- Oliver Dibben3,
- Helen Bright3 and
- Clemens F. Kaminski1,*
- 1Department of Chemical Engineering and Biotechnology, University of Cambridge, Philippa Fawcett Drive, Cambrige, CB2 3AS, UK;
- 2MedImmune Ltd., Sir Aaron Klug Building, Granta Park, Cambridge, UK;
- 3AstraZeneca, Liverpool, UK
- ↵*For correspondence:
r.laine{at}ucl.ac.uk (RFL); cfk23{at}cam.ac.uk (CFK)